Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.585
+0.015 (0.58%)
At close: Apr 28, 2026, 4:00 PM EDT
2.590
+0.005 (0.19%)
After-hours: Apr 28, 2026, 4:04 PM EDT
Nautilus Biotechnology Employees
Nautilus Biotechnology had 130 employees as of December 31, 2025. The number of employees decreased by 25 or -16.13% compared to the previous year.
Employees
130
Change (1Y)
-25
Growth (1Y)
-16.13%
Revenue / Employee
n/a
Profits / Employee
-$453,854
Market Cap
327.17M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 288 |
| Cabaletta Bio | 156 |
| LENZ Therapeutics | 152 |
| Rezolute | 75 |
| Surrozen | 44 |
| Compass Therapeutics | 39 |
| Inhibikase Therapeutics | 35 |
| DiaMedica Therapeutics | 35 |
NAUT News
- 8 hours ago - Nautilus Biotechnology Earnings Call Transcript: Q1 2026 - Transcripts
- 8 hours ago - Nautilus Biotechnology Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 4 weeks ago - Nautilus Biotechnology Transcript: Investor Summit Virtual Conference - Transcripts
- 5 weeks ago - Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform - GlobeNewsWire
- 2 months ago - Nautilus Biotechnology Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Nautilus Biotechnology Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 6 months ago - Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging - GlobeNewsWire